| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |